Virpax Pharmaceuticals Inc

General ticker "VRPX" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $1.8M

Virpax Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -41.7%.

Estimated limits based on current volatility of 4.5%: low 0.32$, high 0.37$

Factors to consider:

  • Current price 80.4% below estimated low
  • Earnings for 9 months up through Q3 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.75$, 5.55$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.57$, 4.60$]

Financial Metrics affecting the VRPX estimates:

  • Negative: Non-GAAP EPS, $ of -13.00 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -68.92 <= 2.35
  • Negative: Industry earnings per price (median), % of -15.01 <= 1.31
  • Negative: Industry operating profit margin (median), % of -70.04 <= 2.14

Similar symbols

Short-term VRPX quotes

Long-term VRPX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $12.03MM $21.85MM $15.69MM
Operating Income $-12.03MM $-21.85MM $-15.69MM
Non-Operating Income $-0.03MM $0.19MM $0.50MM
Interest Expense $0.09MM $0.00MM $0.00MM
R&D Expense $4.84MM $10.76MM $5.12MM
Income(Loss) $-12.06MM $-21.65MM $-15.19MM
Profit(Loss) $-12.06MM $-21.65MM $-15.19MM
Stockholders Equity $37.48MM $16.58MM $1.93MM
Assets $39.57MM $19.67MM $9.63MM
Operating Cash Flow $-14.54MM $-17.85MM $-9.85MM
Financing Cash Flow $51.33MM $0.00MM $0.00MM
Earnings Per Share* $-10.37 $-18.32 $-12.97

* EPS are Split Adjusted, recent splits may be reflected with a delay.